The Effect of Androgen Deprivation Therapy on Prostate Cancer-Specific Mortality in Patients With High-Risk Prostate Cancer Treated with I-125 Brachytherapy as the Sole Radiation Therapeutic Modality

被引：0
|
作者：
Ciezki, J. P. [1 ]
Reddy, C. A. [1 ]
Weller, M. A. [2 ]
Tendulkar, R. D. [1 ]
Stephans, K. L. [1 ]
Klein, E. A. [2 ]
Ulchaker, J. [2 ]
Angermeier, K. [2 ]
Campbell, S. [2 ]
Stephenson, A. J. [3 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Cleveland, OH 44106 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
收藏
页码：E223 / E223
页数：1
相关论文
共 50 条
  • [1] High-risk prostate cancer treated with I-125 brachytherapy.
    Stockham, Abigail Lauren
    Reddy, Chandana A.
    Stephans, Kevin L.
    Ciezki, Jay P.
    Tendulkar, Rahul D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [2] The effect of androgen deprivation therapy on prostate cancer-specific mortality in high-risk prostate cancer: Patients treated with low dose-rate brachytherapy without supplementary external beam radiotherapy.
    Ciezki, Jay P.
    Reddy, Chandana A.
    Weller, Michael A.
    Tendulkar, Rahul D.
    Stephans, Kevin L.
    Ulchaker, James
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [3] Androgen Deprivation Therapy in High-Risk Prostate Cancer
    Buyyounouski, Mark K.
    ONCOLOGY-NEW YORK, 2010, 24 (09): : 806 - 809
  • [4] Treatment timing in localized high-risk prostate cancer treated with radiation and androgen deprivation therapy
    Hasan, Shaakir
    Lazarev, Stanislav
    Gorovets, Daniel
    Garg, Madhur
    Press, Robert H.
    Choi, Isabelle
    Simone, Charles B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer
    Muralidhar, Vinayak
    Xiang, Michael
    Orio, Peter F., III
    Martin, Neil E.
    Beard, Clair J.
    Feng, Felix Y.
    Hoffman, Karen E.
    Nguyen, Paul L.
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2016, 8 (01) : 1 - 6
  • [6] Brachytherapy boost and cancer-specific mortality in favorable high-risk and other high-risk prostate cancer.
    Muralidhar, Vinayak
    Xiang, MIchael H.
    Orio, Peter F.
    Martin, Neil E.
    Beard, Clair
    Feng, Felix Yi-Chung
    Hoffman, Karen E.
    Nguyen, Paul L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [7] Mortality in Men Treated With Radiation Therapy and Androgen Deprivation for High-risk Prostate Cancer in the Modern Era is Driven by Non-prostate Cancer Deaths
    Tendulkar, R. D.
    Hunter, G. K.
    Reddy, C. A.
    Stephans, K. L.
    Ciezki, J. P.
    Stephenson, A. J.
    Klein, E. A.
    Mahadevan, A.
    Kupelian, P. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S94 - S95
  • [8] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Cagney, Daniel N.
    Dunne, Mary
    O'Shea, Carmel
    Finn, Marie
    Noone, Emma
    Sheehan, Martina
    McDonagh, Lesley
    O'Sullivan, Lydia
    Thirion, Pierre
    Armstrong, John
    BMC UROLOGY, 2017, 17
  • [9] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Daniel N. Cagney
    Mary Dunne
    Carmel O’Shea
    Marie Finn
    Emma Noone
    Martina Sheehan
    Lesley McDonagh
    Lydia O’Sullivan
    Pierre Thirion
    John Armstrong
    BMC Urology, 17
  • [10] Prostate Cancer-Specific Mortality and the Extent of Therapy in Healthy Elderly Men With High-Risk Prostate Cancer
    Hoffman, Karen E.
    Chen, Ming-Hui
    Moran, Brian J.
    Braccioforte, Michelle H.
    Dosoretz, Daniel
    Salenius, Sharon
    Katin, Michael J.
    Ross, Rudi
    D'Amico, Anthony V.
    CANCER, 2010, 116 (11) : 2590 - 2595
12345